2025
Risk and predictors of late second primary malignancies in long-term breast, prostate, colon, and rectal cancer survivors.
Kwaramba T, Westvold S, Long J, Hyslop T, Silber A, Lustberg M, Wang S, Leapman M, Leeds I, Cecchini M, Spees L, Wheeler S, Gross C, Dinan M. Risk and predictors of late second primary malignancies in long-term breast, prostate, colon, and rectal cancer survivors. Journal Of Clinical Oncology 2025, 43: 1642-1642. DOI: 10.1200/jco.2025.43.16_suppl.1642.Peer-Reviewed Original ResearchSurvivors of breastRectal cancer survivorsCancer survivorsYears post-diagnosisPost-diagnosisOlder survivorsScreen-detectedSEER-MedicareLong-term cancer survivorsNon-screened cancersLong-term breastStage I-III cancerProstate cancer survivorsIndex cancer diagnosisContinuous Medicare Parts ASEER-Medicare dataModifiable risk factorsMedicare Part ADiagnosis of SPMSurvivorship careSEER-Medicare databaseSurvivorship cohortScreening guidelinesAssociated with shorter timeIndex cancerPersonalized frailty risk assessment in long-term survivors of colorectal cancer.
Forman R, Westvold S, Long J, Fan J, Hyslop T, Yasin F, Conlin K, Jacobson S, Silber A, Wang S, Leapman M, Leeds I, Cecchini M, Spees L, Wheeler S, Gross C, Oeffinger K, Dinan M. Personalized frailty risk assessment in long-term survivors of colorectal cancer. Journal Of Clinical Oncology 2025, 43: 65-65. DOI: 10.1200/jco.2025.43.4_suppl.65.Peer-Reviewed Original ResearchRectal cancer survivorsCancer survivorsElixhauser Comorbidity IndexLong-term survivors of colorectal cancerSurvivors of colorectal cancerClinical prediction modelStage I-III colonCancer diagnosisGastrointestinal cancer survivorsYear 4Area-level povertyAssociated with reduced qualityRisk of frailtyProportion of residentsOnset of frailtyPredictors of frailtyFederal poverty lineIncreased risk of deathAdministrative claims codesSurvivorship managementRisk of deathRetrospective cohort studyAssociated with shorter timePatient raceSevere frailty
2024
Personalized risk assessment of new onset depression in long-term cancer survivors.
Taylor M, Westvold S, Long J, Hyslop T, Wang S, Cecchini M, Leapman M, Leeds I, Lustberg M, Spees L, Wheeler S, Gross C, Oeffinger K, Dinan M. Personalized risk assessment of new onset depression in long-term cancer survivors. Journal Of Clinical Oncology 2024, 42: e13798-e13798. DOI: 10.1200/jco.2024.42.16_suppl.e13798.Peer-Reviewed Original ResearchHistory of depressionIncidence of depressionCumulative incidence of depressionRisk of developing depressionLong-term survivorsPredictors of depressionCancer survivorsDisease specific factorsCumulative incidenceNon-HispanicHigher risk of developing depressionRectal cancerLong-term cancer survivorsBreast cancer survivorsCensus tract povertyColon cancerEpisodes of bipolar I disorderPrevalence of depressionMean survival time modelsDiagnosis of depressionReceipt of treatmentAssociated with prior historyHormone receptor statusPatients aged <Adjuvant endocrine therapy
2023
Demographic and clinical factors associated with cardiovascular events in elderly long-term survivors of breast cancer.
Westvold S, KC M, Fan J, Hyslop T, Spees L, Wang S, Silber A, Oeffinger K, Dinan M. Demographic and clinical factors associated with cardiovascular events in elderly long-term survivors of breast cancer. Journal Of Clinical Oncology 2023, 41: e24105-e24105. DOI: 10.1200/jco.2023.41.16_suppl.e24105.Peer-Reviewed Original ResearchLong-term breast cancer survivorsBreast cancer survivorsLong-term survivorsCardiovascular diseaseCancer survivorsHigh riskCancer stageRace/ethnicityClinical characteristicsDiagnosis yearBreast cancerEvidence of CVDNon-Hispanic black patientsNon-metastatic breast cancerLong-term cancer survivorsCox proportional hazards modelCurative-intent surgeryCVD hazard ratiosNon-oncologic outcomesCancer-specific survivalStage III diseaseInitial cancer diagnosisDiagnosis of CVDRace/ethnicity groupsChi-square testClinician and Cancer Survivor Perspectives on Managing Chronic Pain after Cancer Treatment: A Qualitative Study (Sci216)
Check D, O'Regan A, Jones K, Fish L, Dinan M, Farley S, E. J, Makarushka C, Merlin J, Somers T, Oeffinger K. Clinician and Cancer Survivor Perspectives on Managing Chronic Pain after Cancer Treatment: A Qualitative Study (Sci216). Journal Of Pain And Symptom Management 2023, 65: e648. DOI: 10.1016/j.jpainsymman.2023.02.266.Peer-Reviewed Original ResearchChronic painPalliative care cliniciansCancer survivorsCare cliniciansCancer treatmentCancer survivorshipLong-term opioid therapyRoutine survivorship careCurative-intent treatmentActive cancer treatmentChronic pain managementImpact of painCancer survivors' perspectivesOpioid therapySurvivorship carePain managementActive treatmentMultimodal managementPain carePrimary careHigh prevalencePainCliniciansSurvivorsSurvivors' perspectivesManaging Chronic Pain in Cancer Survivorship: Communication Challenges and Opportunities as Described by Cancer Survivors
O’Regan A, Fish L, Makarushka C, Somers T, Jones K, Merlin J, Dinan M, Oeffinger K, Check D. Managing Chronic Pain in Cancer Survivorship: Communication Challenges and Opportunities as Described by Cancer Survivors. American Journal Of Hospice And Palliative Medicine® 2023, 41: 78-86. PMID: 36927121, DOI: 10.1177/10499091231164634.Peer-Reviewed Original ResearchPain management experiencesCurative-intent treatmentChronic painCancer survivorsPain managementProvider-initiated communicationChronic pain managementHead/neckCancer survivors' experiencesDecision-making interventionSurvivorship careColorectal cancerClinical managementCancer survivorshipPainPain experienceStage ISurvivorsConvenience sampleSurvivors' experiencesTreatmentFunctional goalsCareThematic approachProvidersClinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer Treatment
Check D, Jones K, Fish L, Dinan M, Dunbar T, Farley S, Ma J, Merlin J, O'Regan A, Oeffinger K. Clinician Perspectives on Managing Chronic Pain After Curative-Intent Cancer Treatment. JCO Oncology Practice 2023, 19: e484-e491. PMID: 36595729, PMCID: PMC10530392, DOI: 10.1200/op.22.00410.Peer-Reviewed Original ResearchConceptsChronic painCancer survivorsClinician experienceLong-term opioid therapyMultimodal pain careCurative-intent treatmentBehavioral health servicesAcademic medical centerOpioid therapyOpioid managementActive treatmentPain careHighlights unmetHigh prevalenceClinician's perspectiveMedical CenterMost cliniciansPainMultidisciplinary teamHealth servicesPsychosocial stressorsPain monitoringCliniciansCancer treatmentSurvivors
2021
Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial
Zullig LL, Shahsahebi M, Neely B, Hyslop T, Avecilla RAV, Griffin BM, Clayton-Stiglbauer K, Coles T, Owen L, Reeve BB, Shah K, Shelby RA, Sutton L, Dinan MA, Zafar SY, Shah NP, Dent S, Oeffinger KC. Low-touch, team-based care for co-morbidity management in cancer patients: the ONE TEAM randomized controlled trial. BMC Primary Care 2021, 22: 234. PMID: 34794388, PMCID: PMC8600877, DOI: 10.1186/s12875-021-01569-8.Peer-Reviewed Original ResearchConceptsPrimary care providersCancer survivorsCardiovascular diseaseMedication adherenceCancer specialistsCare providersPrimary care clinic levelInformation Set (HEDIS) quality measuresPharmacy refill dataPrimary care clinicsHealthcare Effectiveness DataHistory of cancerPrimary care physiciansProvider-level interventionsCo-morbidity managementPatient-provider communicationPrimary care teamsBlood pressure measurementsTeam-based careEducation-only controlSequential multiple assignmentCVD comorbidityRefill dataCare clinicsCare physiciansOpioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies
Check DK, Avecilla R, Mills C, Dinan MA, Kamal AH, Murphy B, Rezk S, Winn A, Oeffinger K. Opioid Prescribing and Use Among Cancer Survivors: A Mapping Review of Observational and Intervention Studies. Journal Of Pain And Symptom Management 2021, 63: e397-e417. PMID: 34748896, DOI: 10.1016/j.jpainsymman.2021.10.015.Peer-Reviewed Original ResearchConceptsOpioid useOpioid prescribingCancer survivorsHigh-risk opioid prescribingLong-term opioid useEvidence synthesisContinued opioid useLate opioid usePersistent opioid useProlonged opioid useChronic opioid useUse of opioidsHigh-risk medicationsOpioid use outcomesFull-text reviewTitles/abstractsOpioid misuseChronic useInclusion criteriaExclusion criteriaIntervention studiesInterventional researchPrescribingProlonged useStudy designPredictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims
Check DK, Baggett C, Kim K, Roberts AW, Roberts MC, Robinson T, Oeffinger KC, Dinan MA. Predictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims. Journal Of The National Cancer Institute 2021, 113: 1581-1589. PMID: 33881543, PMCID: PMC8562975, DOI: 10.1093/jnci/djab082.Peer-Reviewed Original ResearchConceptsChronic opioid useChronic opioid therapyOpioid useCancer survivorsOpioid therapyBaseline depressionLong-term pain managementSubstance useRetrospective cohort studyPopulation-based studyCancer registry dataLow-income survivorsCohort studyPatient characteristicsPain managementActive treatmentNonmetastatic cancerChronic useInsurance statusRelative riskRegistry dataOpioidsPoisson regressionYounger ageAge groups
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply